Comparison of the results of the study of cellular technologies in the treatment of ischemic cardiomyopathy in different epochs of drug therapy

Authors

  • Kemelbekov Baglan Satybaldyuly PhD-student of “West Kazakhstan Medical University named after Marat Ospanov”, cardiologist, Aktobe city, Republic of Kazakhstan
  • Amanzholqyzy Aynur PhD, associate Professor of normal physiology department “West Kazakhstan Medical University named after Marat Ospanov”, Aktobe city, Republic of Kazakhstan.
  • Edgaras Stankevicius PhD, MD Professor of normal physiology department, «Lithuanian University of Health Sciences», Kaunas city, Lithuania
  • Saparbayev Samat Sagatovich PhD, associate professor, medical center “Al-Zhami” Aktobe city, the Republic of Kazakhstan
  • Yerlan Orazymbeto PhD-student of «Lithuanian University of Health Sciences», врач кардиохирург, Kaunas city, Lithuania+77023210021
  • Jaxalykova Kulyash Department of Neonatology, Astana Medical University
  • Sarkyt Kozhabergenovna Kozhantayeva Head of the Department of Otolaryngology and Ophthalmology, Doctor of Medical Sciences
  • Sh B Kosmuratova Ph.D., Associate Professor of the Normal Physiology Department,“West Kazakhstan Marat Ospanov Medical University” NCJSC, Aktobe, the Republic of Kazakhstan
  • Ainur Donayeva PhD, HEAD OF THE EMERGENCY MEDICAL CARE DEPARTMENT, A.Donayeva

DOI:

https://doi.org/10.3329/bjms.v24i2.81724

Keywords:

Comparison, cellular technologies, cardiomyopathy, drug therapy.

Abstract

Background Currently, it is obvious that stem cell therapy opens up prospects for the treatment of certain diseases, but at the same time it faces serious problems. First, most clinical data indicate a positive effect of stem cell transplantation on heart repair, regardless of cell types and methods of their delivery. Objectives Comparison of the results of the study of cellular technologies in the treatment of ischemic cardiomyopathy in different epochs of drug therapy Methods The researched studies obtained from the PubMed and Scopus Preview databases are presented in two tables. The first table shows the studies of group “A” for the period 2004-2010. Results The results of the studies of the first group “A” (2004-2010) were as follows: in studies like T. Siminiak et al. (2004), N.Dib et al. (2005), A.A. Hagege et al. (2006), M. Haack‐ Sorensen et al. (2008) (MSC-HF), Hare J.M. et al. (2009), Assmus B. et al. (2010), Strauer B.E. et al. (2010) (STAR- heart research); Wang S. and co-author. (2010), Mansour S. et al. (2010) (COMPAREAMI study) stem cells used in ischemic cardiomyopathy had a positive effect on the myocardium. Conclusion The results of the analysis of the studies showed the following: given the changes in the tactics of drug therapy of CHF over time, there was no significant difference in the results between the two groups of studies on the use of stem cells in ischemic cardiomyopathy.

Bangladesh Journal of Medical Science Vol. 24 No. 02 April’25 Page : 554-559                      

Downloads

Abstract
122
PDF
127

Downloads

Published

2025-05-17

How to Cite

Satybaldyuly, K. B., Aynur, A., Stankevicius, E., Sagatovich, S. S., Orazymbeto, Y., Kulyash, J., … Donayeva, A. (2025). Comparison of the results of the study of cellular technologies in the treatment of ischemic cardiomyopathy in different epochs of drug therapy. Bangladesh Journal of Medical Science, 24(2), 554–559. https://doi.org/10.3329/bjms.v24i2.81724

Issue

Vol. 24 No. 2 (2025)

Section

Original Articles

License

Copyright (c) 2025 Kemelbekov Baglan Satybaldyuly, Amanzholqyzy Aynur, Edgaras Stankevicius, Saparbayev Samat Sagatovich, Yerlan Orazymbeto, Jaxalykova Kulyash, Sarkyt Kozhabergenovna Kozhantayeva, Sh B Kosmuratova, Ainur Donayeva

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.